TMT1B ablation was found to inhibit the pro-migratory activity of TGF-β in thyroid cancer cells, where loss of TMT1B inhibited the decrease of E-cadherin and increase of N-cadherin typically seen during TGF-β-induced EMT (33). The gene discussed is TMT1B; the disease is thyroid cancer.